United States News Todas as matérias

Immunovant (NASDAQ:IMVT) reported topline results from Period 1 of its proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.

Oruka Therapeutics (NASDAQ:ORKA) reported positive Week 28 results from the Phase 2a EVERLAST-A trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.

AC Immune (NASDAQ:ACIU) reported that all primary endpoints were met at week 100 in Part 1 of its Phase 2 VacSYn trial evaluating ACI-7104 in early Parkinson’s disease.

Sharon AI (NASDAQ:SHAZ) is collaborating with VAST Data to offer VAST DataEnclave confidential AI capabilities through its AI Factory platform across Australia and Asia-Pacific.

Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, an increase of 10.9% from $2.72 billion in the prior-year period.

Viasat (NASDAQ:VSAT) secured a $42 million initial task order under a seven-year U.S. Marine Corps satellite communications contract announced on September 23, 2026.

SLB (NYSE:SLB) received a contract from OQ Exploration & Production (OQEP) to deliver the Bisat-B Expansion Production Facility in Oman.

HUHUTECH (NASDAQ:HUHU) reported first-half 2026 revenue of $10.67 million, an increase of 8.6% from the prior-year period, supported by contributions from new international operations.

Roivant (NASDAQ:ROIV) reported topline results from Immunovant’s proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.

IM Cannabis (NASDAQ:IMCC) signed a non-binding letter of intent to acquire 51% of Space Defense Innovations (SDI), a Poland-based company operating in the European unmanned aerial systems market.

Best Buy (NYSE:BBY) and Amazon (NASDAQ:AMZN) expanded their multiyear Fire TV partnership to continue providing Fire TV software on Insignia TVs and introduce new connected TV advertising opportunities.

Blue Moon (NASDAQ:BMM) signed a definitive agreement to acquire the Turner copper-gold VMS deposit in Oregon from Gold Coast Mining through a combination of cash, shares, and milestone payments.

Cracker Barrel (NASDAQ:CBRL) reported fourth-quarter fiscal 2026 revenue of $849.3 million, with higher profitability despite lower sales compared with the prior year.

General Mills (NYSE:GIS) reported first-quarter fiscal 2027 net sales of $4.4 billion, down 3% from the prior year due mainly to the impact of the U.S. yogurt business divestiture.

Manchester United (NYSE:MANU) reported record fiscal 2026 revenue of £677.6 million for the year ended June 30, 2026, while returning to operating profit.

ANI Pharmaceuticals (NASDAQ:ANIP) received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Everolimus Tablets for Oral Suspension.

RPM International (NYSE:RPM) signed a definitive agreement to acquire Volteco S.p.A., an Italy-based supplier of below-grade waterproofing solutions, for its Tremco Construction Products Group.

Surf Air Mobility (NYSE:SRFM) signed a definitive agreement with SkyDance Air for OperatorOS, its SurfOS flight operations software platform powered by Palantir Technologies (NASDAQ:PLTR).

AEVEX Corp. (NYSE:AVEX) announced Specter, a jet-powered autonomous platform under development using modular design and scalable manufacturing methods.

Target Corporation (NYSE:TGT) declared a regular quarterly dividend of $1.16 per common share, payable on December 1, 2026.

Meta Platforms (NASDAQ:META) is expected to unveil new smart glasses at its annual Connect conference, including a camera-free model amid growing privacy concerns.

NW Natural Holding Company (NYSE:NWN) said its SiEnergy subsidiaries reached a settlement with key parties in a Texas general rate case that includes an $8.6 million annual revenue increase.

Cardiol Therapeutics (NASDAQ:CRDL) reached its original enrollment target for the Phase III MAVERIC trial of CardiolRx in recurrent pericarditis and plans to expand enrollment to up to 150 patients.

Kimberly-Clark (NYSE:KMB) offered concessions to address European Union antitrust concerns regarding its proposed $40 billion acquisition of Kenvue (NYSE:KVUE), according to a European Commission filing.